Preclinical and early clinical studies support their neuroprotective, anti-inflammatory, and synaptic benefits in conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis
I dont know. For another sense of the stakes: Anil told me that he reached out to 150 outside researchers to find five who would speak to him, which I think shows the fear people have about losing their funding, he said in a DM
However, no clinical trials have been reported that provide any evidence of its effectiveness for raising the chronically low homeostatic level of glutathione that occurs in primary mitochondrial diseases [1, 11]
BPC-157 BPC-157, also known as Body Protection Compound-157, is a man-made pentadecapeptide with a 15-amino-acid chain
Evaluation of lipid peroxidation, oxidant/antioxidant status, and serum nitric oxide levels in alopecia areata Med Sci Monit
References Alosi, M